| Dr Dana Eric Berry, DDS | |
|
7970 Lander Ave, Suite B, Hilmar, CA 95324-8350 | |
| (209) 262-1817 | |
| (209) 262-1816 |
| Full Name | Dr Dana Eric Berry |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 7970 Lander Ave, Hilmar, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194984948 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 47596 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dana Eric Berry, DDS 1140 Main St, Livingston, CA 95334-1257 Ph: (209) 394-9713 | Dr Dana Eric Berry, DDS 7970 Lander Ave, Suite B, Hilmar, CA 95324-8350 Ph: (209) 262-1817 |
News Archive
The Academy of Nutrition and Dietetics applauds the Food and Drug Administration's efforts, announced November 7, to reduce partially hydrogenated oils in processed foods.
Uroplasty, Inc. announced today that its underwritten public offering of 4 million shares of its common stock was priced at $3.50 per share. Uroplasty has granted the underwriters of the offering an option to purchase up to an additional 600,000 shares of common stock within the next 30 days, solely to cover over-allotments, if any. All of the shares in the offering are being offered by Uroplasty. Uroplasty expects the offering to close on July 27, 2010, subject to customary closing conditions.
An international study involving 467 hospitals in 12 countries found that doctors do a good job of aggressively treating the early stages of heart attacks - even before laboratory tests confirm the diagnosis.
The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named the first recipients of the Dale F. Frey Award for Breakthrough Scientists. This new award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer.
Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response when treated with the novel oral Janus kinase inhibitor tofacitinib at 10mg BID compared to 31.2 percent in the placebo group. Significant improvements were also observed in the 5 mg BID dose.
› Verified 5 days ago
Dr. Gurmeet Singh, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7970 Lander Ave Ste B, Hilmar, CA 95324 Phone: 209-262-1819 Fax: 209-262-1817 | |
Dr. Michael B Hansted, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 19901 1st St, Hilmar, CA 95324 Phone: 209-668-0101 | |
Dr. Maria Naanaa, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7970 Lander Ave Ste A, Hilmar, CA 95324 Phone: 209-262-1816 | |
Dr. Remya Niranjan, Dentist Medicare: Not Enrolled in Medicare Practice Location: 7970 Lander Ave, Hilmar, CA 95324 Phone: 209-262-1819 Fax: 209-262-1817 |